Diagnosis Kit for the Detection of Respiratory Virus Infections and Patient Prognosis
Consorcio Tecnologico en Biomedicinaclinico-molecular S. A.
Mauricio Bulnes Bulnes Carrasco
MetadatosMostrar el registro completo del ítem
Diagnosis kit for the detection of respiratory virus infections and patient prognosis. The project includes the development of a clinical diagnostic test for simultaneous detection of respiratory viruses (respiratory syncytial virus (RSV) adenovirus (ADV) human metapneumovirus (hMPV) influenza and parainfluenza (PIV)). The kit also includes the detection of molecules produced by the host in response to viral infection as a parameter that indicates the severity of the patient's immune response to infection allowing the physician to take the best decision for the patient's treatment. The test possesses high sensitivity and specificity and low or intermediate technical complexity (in terms of human resources and laboratory equipment for use) altogether allowing accurate fast and reliable results. We believe that this test should be less expensive than current diagnostic methods (IFI PCR) therefore we estimate that the product will be an important alternative to traditional diagnostic methods for determining viral infections. Its incorporation into health services will help optimizing the treatment in these centers through fast and appropriate diagnosis. We estimate that this diagnostic kit will be perceived by the medical community as a major contribution which in turn will allow its massive incorporation in the healthcare market. We believe that the project includes an innovative design and high technical feasibility. It also represents an excellent business opportunity because of the huge market potential related to respiratory infections making it a product of high social and economic impact.